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Abstract 
 
As the traditional Chinese medicine, the fresh fruits of Amorpha fruticosa L. were applied for the treatment of 
carbuncle, eczema and burn (Das et al., 2007). However, little is known about the functional roles of the fruits of Amorpha 
fruticosa L. during wound healing progress. In the present study, we evaluated both antimicrobial potential against a wide 
range of microorganisms and wound healing activity of the seven compounds isolated from the fruits of Amorpha fruticosa L 
in vitro and in vivo. Our results showed that compounds I (6a,12a–dehydroamorphin), V (dehydrosermundone) and VI 
(tephrosin) isolated from the fruits of Amorpha fruticosa L. performed dominant antimicrobial potential against 
microorganisms. Moreover, these compounds significantly enhanced fibroblasts proliferation and migration, leading to 
promotion of wound healing. Thus, it could be possible for the therapeutic utilization of Amorpha fruticosa L. for wound 
healing in the future. 
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Introduction 
 
The use of plant makes it possible to double our life span in the 20th century and the natural products from plants have 
been an overwhelming success in modern society. Amorpha fruticosa L. is a shrub plant belonging to the genus Amorpha in 
Leguminosae family (Lee et al.,2006). There are about twenty-five species plants in genus Amorpha in the whole world. 
Only the species fruticosa had been introduced to be planted in China and had a wide distribution in Liaoning Province of 
China. The therapeutic utilization of Amorpha fruticosa L. for wound healing could date back to the beginning of civilization 
(Das et al., 2007). As the Traditional Chinese Medicine theories described, the fresh fruits of Amorpha fruticosa L. were 
applied for the treatment of carbuncle, eczema and burn (Das et al.,2007). In the China, Record of Natural Resources of 
Chinese Materia Medica, the effectiveness of dried fruits of Amorpha fruticosa L. was applied as paste externally twice or 
thrice a day for wound-healing purpose (Liu et al.,2005). 
Wound healing is a complex, integrated series of biochemical, cellular and physiological processes (Martin, 1997). The 
purpose of repairing events is to resist pathogens invasion, establish the integrity of the damaged tissue and reconstruct 
physiological function of skin. The healing process in full-thickness skin wounds includes inflammation, wound contraction, 
development of granulation tissue, scar formation and tissue remodeling (Singer and Clark, 1999) which are concurrent but 
independent to each other. During wound reparation progress, a critical step is the proliferation and migration of the resident 
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epidermal keratinocytes and dermal cells from the wound edge and surrounding epidermis to the wound bed (Babu and Wells, 
2001; Eming et al., 2007). The dermal cells, including dermal fibroblasts and dermal microvascular endothelial cells, 
perform important function in this reparation process. Topical application of compounds with enhancement of dermal cells 
proliferation and migration is to improve significantly wound healing (Pan et al., 2010). In previous study, we reported the 
isolation from the PE、AcOEt and n-BuOH of the fruits of Amorpha fruticosa L. Seven compounds were obtained and their 
structures were elucidated (Wang et al., 2010), and we evaluated both antimicrobial potential against a wide range of 
microorganisms and wound healing activity of the seven compounds isolated from the fruits of Amorpha fruticosa L. in vitro 
and in vivo.  
 
Experimental Section 
Plant 
 
The fruits of Amorpha fruticosa L. were collected from Dalian City of Liaoning province, China in July. It was 
authenticated by vice Prof. Yun-peng Diao, college of pharmacy, Dalian Medical University and a voucher specimen has 
been deposited in pharmacognosy laboratory under specimen number AF0017. 
 
Cells, animals and microorganisms 
 
The mouse fibroblast cell line (L929) was obtained from Chinese Academy of Sciences and cultured in RPMI 1640 
supplemented with 10% fetal bovine serum, 100 U/ml penicillin and 100μg/ml streptomycin. All cells were cultured in a 
humidified atmosphere of 5% CO2 at 37℃. Healthy, male, Sprague-Dawley rats, weighing 200-220g, were supplied by the 
Animal Experimental Center of Dalian Medical University and housed one per cage for a week before the study in a room 
with controlled environment (12-h light/dark cycle, 23±2℃ and relative humidity 70%). They were also allowed free access 
to standard laboratory diet and water. All experimental procedures were approved by the Animal Research Ethics Committee 
of Dalian Medical University, Dalian, China. The Bacterial (Bacillus subtilis, Bacillus cerculences, Staphylococcus aureus, 
Escherichia coli, Pseudomonas aeruginosa and Klebsiella aeruginosa) were got from China Center for Type Culture 
Collection. 
 
Wound healing test in vitro 
MTT assay 
 
The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT)  viability assay was performed as 
previously described with the following  modification (Do et al.,2008). Briefly, cells were seeded into 96-well plate with 
0.6×104 cells/well.  After 24 h attachment, various concentrations (1–1000μg/ml) of seven compounds were applied to the 
cells in serum-free RPMI 1640, and incubation was extended for another 48 h. Then the cells were washed with PBS and 200 
μl MTT (0.5 mg/ml) was added to each well and further incubated for 4 h. The MTT solution was carefully removed by 
aspirating, and the formazan product was dissolved in 150 ml DMSO. Absorbance was measured at 570nm on a microplate 
reader (Bio-TEK Instrument, Winooski, VT). 
 
Transwell assay 
 
The migration activity of fibroblasts was performed using 24-well transwell chamber with 8.0um pore polycarbonate filter 
inserts (Costar, Cambridge, MA, USA). Cells (3×104 cells/well) suspended in serum-free RPMI 1640 containing 0.1% BSA 
were overlaid in the upper chamber of each transwell. In each lower chamber, 500ul of serum- free RPMI 1640 containing 
0.1% BSA in the presence or absence of compounds was added. Then the inserts were incubated at 37℃ in a humidified 
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atmosphere containing 5% CO2 for 24h. The cells that had not penetrated the filters were removed using cotton swabs. The 
migrated cells attached to the bottom side were fixed in 100% methanol for 10 min and stained with Wright–Giemsa. The 
cells migrating the lower surface of the filter in five microscopic fields of 400× magnification were counted in each filter. 
Triplicate samples were acquired and the data were expressed as the average cell number of 15 fields. 
 
 
Structures of seven compounds 
 
The compounds were named as 6a,12a–dehydroamorphin(I), D–3–O–methyl–chiro–inositol(II), Kaempferol-3-gluco- 
7-rhamnoside(III),7,2′,4′,5′-tetrom–ethoxy-isoflavone(IV),dehydrosermundone(V),tephrosin(VI),7,4′-dimethoxyisoflav
one(VII). Their structures are showed as followed: 
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Wound healing test in vivo 
Drug formulations 
 
Based on preliminary screening, dose-response study of seven compounds isolated from the fruits of Amorpha 
fruticosa L. were performed to determine the optimal concentration range. For the present study of wound healing evaluation 
in vivo, seven 10%(w/w) ointment were prepared, with 5 mg of every compound formulated with 50 mg of Vaseline. 
 
Excision wounds model 
 
A total of 54 rats were randomly divided into nine groups of six animals each. The animals were anesthetized by an 
intra-peritoneal injection of 10% chloral hydrate (0.3ml/100g), and the dorsal surface of the rat was shaved and the 
underlying skin was cleaned with povidone iodine. An excision wound was created on the dorsal aspect of the rats by cutting 
away a 500mm2 full thickness of skin. The seven experimental groups received isolated compounds’ ointment. The control 
group received the vehicle alone. The positive group received recombinant human epidermal growth factor (rhEGF) 
ointment. All drugs were applied topically once a day until the wounds completely healed. The wounds were measured every 
other day by placing a transparent paper over the wound and tracing it out. The parameters studied were percentage wound 
contraction calculated using the following formula: percent wound contraction = (original wound area - unhealed 
area)/original wound area ×100%.  
 
Incision wounds model 
 
A total of 54 rats were randomly divided into nine groups of six animals each. After anesthesia, disinfection and skin 
preparation, a paravertebral long incision of 4 cm length was made through full thickness of the skin at a distance about 1.5 
cm from the middle on right side of the back. The wounds were closed with interrupted sutures of 0.5cm apart using using 
sterile surgical thread (No. 000) and a curved needle (No. 11) ( Udupa et al.,1995). The nine groups were treated with the 
same manner as the excision model for 9 days. On day 9, sutures were removed and the tensile strength of healed wounds 
was measured with a tensiometer and calculated using the following formula: tensile strength = breaking strength/ cross 
sectional area of skin. 
 
Determination of the hydroxyproline content 
 
On the day 22 after excision wounds creation, the healed wound tissues were excised and analyzed for hydroxyproline 
content, which is a basic constituent of collagen. Tissues were dried in a hot air oven at 60℃ to constant weight and were 
hydrolysed in 6N HCl at 130 ℃for 4 h in sealed tubes. The hydrolysate was neutralised to pH 7.0 and was subjected to 
Chloramine-T oxidation for 20 min. The reaction was terminated by addition of 0.4M perchloric acid and colour was 
developed with the help of Ehrlich reagent at 60℃ (Woessner, 1961) and measured at 560 nm using a spectrophotometer. 
 
Histological examination  
 
The excised tissue of excision wounds was fixed in 10% neutral buffered formalin, dehydrated in graded ethanol, 
cleared in xylene, and embedded in paraffin. Five-micron-thick sections, including the epidermis, the dermis, and the 
subcutaneous panniculus carnosus muscle, were mounted on glass slides, dewaxed, rehydrated in distilled water, and stained 
with hematoxylin and eosin(HE). All subsequent analyses were performed by an experienced pathologist without knowledge 
Qu et al., Afr J Tradit Complement Altern Med. (2013) 10(3):458-468 
http://dx.doi.org/10.4314/ajtcam.v10i3.12 
462
of the previous treatment to evaluate the degree of re-epithelization, granulation tissue formation and collagen organization 
in the wound 
 
Antimicrobial activity 
Minimal Inhibitory concentration (MIC) determination 
 
 Minimum inhibition concentration assay was performed in nutrient broth containing 0.05% phenol red and 
supplemented with 10% glucose (NBGP). All the test compounds were initially dissolved in DMSO and the solution 
obtained was added to NBGP to a final concentration of 5000 μg/ml for each crude extract. This was serially diluted by 
twofold, to obtain concentration ranging from 5000 μg/ml to 4.9 μg/ml. One hundred microlitres of each concentration was 
added to a 96-well microplate containing 95μl of NBGP and 5 μl of standard inoculum, the appropriate inoculums size for 
standard MIC was 105 CFU/ml. The final concentration of DMSO in the well was less than 1%. The negative control well 
was composed of 95 μl of NBGP and 5 ul of the standard inoculum. Chlormycetin was taken as the positive control and the 
concentration was diluted from 64 μg/ml to 0.063 μg/ml. The plates were covered with a sterile plate sealer, then agitated to 
mix the content of the wells using a plate shaker and incubated at 37 ℃ for 24 h. The assay was repeated twice and microbial 
growth was determined by observing the chromatic change in the wells (red when there is no growth and yellow when there 
is growth). The lowest concentration demonstrating no color change in the well was considered as the MIC (Dash et al., 
2001). 
 
Minimum bactericidal concentrations (MBC) 
 
For the determination of MBC, a portion of liquid (5ul) from each well that showed no change in color was plated on 
agar plate and incubated at 37℃ for 24 h. The lowest concentrations that yielded no growth after this sub-culture were taken 
as the MBC (Srinivas et al.,2008). 
 
 
Results  
Wound healing activity in vitro 
Cell viability of fibroblast 
 
MTT cell viability assay was performed in response to different concentrations of the seven compounds. The result 
demonstrated that at lower concentrations (1 and 10μg/ml)，no clear effect was seen with all compounds. At higher 
concentrations (100 and 1000 μg/ml), only compoundⅠand Ⅴ increased cell viability (p＜0.05), but the cell viability was 
no significant difference with the concentration of 100 μg/ml and 1000 μg/ml (p＞0.05)(Figure 1). So 100ug/ml of seven 
compounds was used in the following experiments. 
 
Cell migration of fibroblast 
 
Transwell assay is a commonly used model for analyzing the molecular mechanism underlying cell migration. With 
this migration assay, the fibroblasts were cultured in serum-free media with 1% BSA for 24 h in the presence or absence of 
seven different compounds. The results showed that compound I and V significantly induced cell migration at 100 μg/ml 
compared with control group and other five compounds (p＜0.05), and there is no difference within the above two 
compounds (p＞0.05) (Figure 2). 
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Wound healing activity in vivo 
The percent wound contraction of excision wounds 
 
Starting from day 4 to day 16 after wound creation, the wound contraction of compound Ⅰ, Ⅴ and positive control 
group was found to be significant compared with negative control group and other compounds (p＜0.05). On day 18, 
wounds in compounds Ⅰ, Ⅴ and positive control treated group healed completely. Wounds in other five compounds and 
negative control treated group did not heal until day 22 after wound creation (Table 1). 
 
Tensile strength of incision wounds and hydroxyproline content of excision wounds 
 
The tensile strength and hydroxyproline content in compound Ⅰ and positive control treated group was the highest, 
and significantly higher than negative control treated group (p＜0.01). The above two healing parameters in compound Ⅴ 
was also higher than negative control treated group (p＜0.05). In contrast, the difference between other four compounds and 
negative control treated group was not found to be statistically significant (Table 2). 
 
Histological examination 
 
When the excision wound healed, the tissue was excised to evaluate the healing quality under light microscope. The 
progression of new epithelium, granulation tissue formation and collagen organization related to wound healing in 
compound Ⅰ, Ⅴ and positive control group were better compared to compound Ⅱ,Ⅲ,Ⅳ,Ⅵ,Ⅶ and negative group. Wounds 
in compound Ⅰ, Ⅴ and positive control group demonstrated that the collagen fiber was more matured with few capillaries, 
robust fusiform fibrocytes and regenerative folliculus and sebaceous glands. In contrast, in compoundⅡ,Ⅲ,Ⅳ,Ⅵ,Ⅶ and 
negative control group, there was more granulation tissue within the wound bed showing poorly-organized capillary, many 
fibroblast, moderate collagen and no regenerative folliculus or sebaceous glands. In addition, compared with compound 
Ⅱ,Ⅲ,Ⅳ,Ⅵ,Ⅶ  and negative group, a thicker continuous epithelial line covering the whole wound bed was observed in 
compound Ⅰ, Ⅴ and positive control group (Figure 3). 
 
Antimicrobial activity  
 
Among the seven compounds(Ⅰ- Ⅶ) from the fruits of Amorpha fruticosa L, compound Ⅰ, Ⅴ and Ⅵ exhibited 
higher inhibitory effect towards all the pathogens than other four compounds. The MIC and MBC of these compounds 
against pathogens was summarized in Table 1. The results showed that Bacillus subtilis, Staphylococcus aureus and 
Pseudomonas aeruginosa were most sensitive to compound  Ⅵ. Bacillus cerculences was most sensitive to compound Ⅰ 
and Ⅵ equally. Escherichia coli was most sensitive to compound Ⅴ, and Klebsiella aeruginosa was most sensitive to 
compound Ⅰ respectively (Table 3).  
 
Discussion 
 
Wound healing involving interactions of multiple cell types, various growth factors, their mediators, and the 
extracellular matrix proteins is a complicated biological process. Physiological healing of wound takes place by itself and 
does not require much other intervention, but some risk factors such as the defect of local blood supply and infection could 
delay the healing process (Keeling et al., 2010; Leaper,2010). Many natural products based on plant have been found to have 
therapeutic effects as promoters of wound healing (Woollard et al., 2007; Skórkowska-Telichowska et al., 2010). Amorpha 
fruticosa L. leaves and fruits have been used for treating wounds in traditional medicine. In previous study of our laboratory, 
the compounds isolated from Amorpha fruticosa L. were mainly rotenoids, which have demonstrated many pharmacological 
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activities, such as antitumor, antivirus and antibacterial action, inhibition of phosphodiesterase, hepatoprotection, fish poison 
and insecticide activity (Petkov et al., 1983;Li et al., 1993). The results of present study using wound healing experiments in 
animal models, biochemical analysis of wound biopsy, and in vitro studies showed that three different compounds isolated 
from the fruits of Amorpha fruticosa L. have antibacterial activity and promote the healing of wounds.  
Table 1 .The percent wound contraction of excision wounds at different time point 
 
Group Day 2 Day 4 Day 6 Day 8 Day 10 Day 12 
Compound 
Ⅰ 
17.9±1.0 36.2±1.8* 43.5±2.0* 62.6±2.1* 77.3±1.8* 86.1±2.4* 
Compound 
Ⅱ 
16.0±1.1 30.2±1.3 37.6±2.2 57.4±1.6 64.8±1.9 76.3±1.8 
Compound 
Ⅲ 
16.5±1.3 31.0±1.1 39.3±2.9 56.8±2.0 63.3±1.6 76.1±2.6 
Compound 
Ⅳ 
15.7±1.5 32.1±2.0 39.5±1.9 56.1±2.2 64.1±1.4 77.0±1.6 
Compound 
Ⅴ 
16.8±1.0 35.7±1.6* 42.4±2.4* 60.7±3.1* 76.9±3.1* 85.2±2.3* 
Compound 
Ⅵ 
16.2±0.9 31.9±1.0 38.0±2.1 58.3±2.5 65.8±2.3 75.2±2.1 
Compound 
Ⅶ 
17.3±1.0 31.1±1.3 38.3±3.0 54.9±2.5 63.5±1.5 75.9±1.6 
Positive 
control 
18.3±1.4 39.3±1.5* 45.2±2.3* 63.7±1.4* 77.4±2.6* 86.6±2.7* 
Negative 
control 
16.2±1.1 31.5±2.1 38.2±1.7 55.5±2.0 63.6±1.9 75.7±2.1 
Group Day 14 Day 16 Day 18 Day 20 Day 22  
Compound 
Ⅰ 
90.7±2.0* 96.8±1.9* 100* 100* 100 
 
Compound 
Ⅱ 
82.4±1.4 87.5±1.9 92.5±2.1 96.3±2.1 100 
 
Compound 
Ⅲ 
83.7±1.5 88.5±1.9 91.7±2.0 96.9±1.1 100 
 
Compound 
Ⅳ 
84.3±3.1 87.9±1.6 92.8±2.1 96.3±1.4 100 
 
Compound 
Ⅴ 
90.5±2.0* 96.1±1.1* 100* 100* 100 
 
Compound 
Ⅵ 
84.9±2.3 89.1±2.7 93.5±3.1 97.0±1.4 100 
 
Compound 
Ⅶ 
82.9±2.6 87.0±2.6 93.0±1.2 96.5±1.3 100 
 
Positive 
control 
92.1±1.9* 97.3±1.1* 100* 100* 100 
 
Negative 
control 
83.4±1.5 87.2±3.1 92.2±2.3 95.4±1.8 100 
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Values are mean ± S.D.  
*P<0.05 as compared to negative control group. 
 
 
Table 2: Tensile strength of incision wounds and hydroxyproline content of excision wounds 
 
  Tensile strength(g/cm2) Hydroxyproline(mg/g tissue) 
Compound Ⅰ 547.3±7.9# 80.3±4.4# 
Compound Ⅱ 431.5±8.3 63.1±5.1 
Compound Ⅲ 440.3±7.4 58.4±3.7 
Compound Ⅳ 451.8±6.0 63.6±4.9 
Compound Ⅴ 500.2±8.9* 70.7±4.2* 
Compound Ⅵ 442.0±8.1 63.2±5.9 
Compound Ⅶ 449.8±6.4 59.3±4.7 
positive control 568.1±8.3# 84.6±5.3# 
Negative control 436.5±7.6 60.2±4.1 
Values are mean ± S.D. 
#P<0.01 as compared to negative control group 
*P<0.05 as compared to negative control group 
 
Table 3: MIC and MBC of compounds from Amorpha fruticosa L against different bacteria (μg/ml) 
Bacillus subtilis   Bacillus cerculences   Staphylococcus aureus 
compounds 
MIC MBC   MIC MBC   MIC MBC 
Ⅰ 156.3 312.5  156.3 312.5  156.3 156.3 
Ⅱ — —  — —  — — 
Ⅲ 2500 2500  1250 2500  — — 
Ⅳ 1250 1250  1250 2500  5000 5000 
Ⅴ 156.3 312.5  312.5 312.5  78.2 156.3 
Ⅵ 156.3 156.3  156.3 312.5  78.2 78.2 
Ⅶ 2500 2500  5000 5000  2500 2500 
Chlormycetin 
1 2   1 2   2 4 
Escherichia coli   
Pseudomonas 
aeruginosa 
  Klebsiella aeruginosa 
 
MIC MBC   MIC MBC   MIC MBC  
312.5 312.5  312.5 312.5  156.3 312.5  
— —  — —  — —  
— —  — —  — —  
2500 2500  5000 5000  2500 2500  
156.3 156.3  312.5 312.5  312.5 312.5  
156.3 312.5  156.3 156.3  312.5 312.5  
1250 2500  — —  2500 2500  
0.5 1   1 2   1 2  
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Figure 1: Viability of fibroblasts after different compounds treatment measured with MTT assay. Cells were exposed to 
gradually increased concentration of different compounds. The results are represented as a percentage of absorbance 
relative to control cells (100%). * Differ (P<0.05) from the control 
 
 
Figure 2: Effect of different compounds on fibroblast migration activity in transwell assay. After treated with compound 
Ⅰ(B) and Ⅴ(C) , the fibroblasts demonstrated significant capability of migration, compared with absence of any 
compounds(A). 
 
 
Figure 3: Histological compare in the character of excision wound healing (100× magnification). Wounds of all groups 
demonstrated a continuous epithelial line covering the whole wound bed. However, the epithelium was thicker in 
compared with negative control group. Moreover, in compoundⅠ(A)andⅤ(B)group, the granulation was matured 
showing capillary vertically oriented, robust fusiform fibrocytes and moderate well-arranged collagen. In contrast, in 
negative control group(C), the granulation tissue was un-matured with capillary poorly-organized, many fibroblast and 
slight collagen formation. 
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Fibroblast is a major cell type participating in wound healing process which is responsible for the synthesis, deposition, and 
remodeling of the extracellular matrix (Hinz,2010). During wound repair, fibroblasts initially proliferate in situ, then migrate 
from the wound edges to the wound site, proliferate again, and subsequently produce collagen (Werner et al.,2007). Collagen 
is a crucial constituent of extracellular matrix and the amount of hydroxyproline is a reflection of concentration of collagen 
(Bhattacharjee and Bansal, 2005). Therefore, the more hydroxyproline represents the faster rate of collagen synthesis 
corresponding to enhanced wound healing. In present study, according to the results of MTT assay and transwell assay 
which is widely used for detection of cell proliferation and migration activity in vitro, compound Ⅰ,Ⅴ and Ⅵ isolated from 
the fruits of Amorpha fruticosa L. demonstrated significantly enhanced effect on fibroblasts in proliferation and migration, 
thus promoting wound healing. And this finding was further confirmed by biochemical assay for hydroxyproline content in 
vivo, which means collagen synthesis was improved after topical application of related compounds, so that the amount of 
collagen increasing was one of the reasons for the wound healing promotion. 
When wound healing starts, it is prone to be attacked by bacteria. It is well known that infections may delay wound healing 
and cause failure of healing, even wound deterioration (Guo and Dipietro,2010). Microbial pathogens delay wound healing 
through several mechanisms, including persistent production of inflammatory mediators, metabolic wastes and toxins; 
causation of tissue hypoxia, the granulation tissue hemorrhagic and fragile; reduction of fibroblast number and collagen 
production; continuous activation of neutrophils, which produce cytolytic enzymes and free oxygen radicals, and 
competition with host cells for nutrients and oxygen necessary for wound healing (Macri and Clark,2009). Thus, keeping the 
wound axenic or maintaining a low bio-burden is a crucial aim in wound healing. In the present study, the inhibitory effects 
of seven compounds isolated from the fruits of Amorpha fruticosa L on six strains referring to Gram positive and Gram 
negative bacteria growth were evaluated. As a result of rotenoids structure, the compounds Ⅰ, Ⅴ and Ⅵ demonstrated a 
more significant antibacterial effect comparing with other four compounds. To our knowledge, in aerobic organisms the 
rotenone-insensitive enzymes provide at least two vitally important functions. First, they can reduce NADH produced by 
multiple dehydrogenases, thus not maintaining and controlling general oxidative metabolism. Second, they also never serve 
as the energy-transducing devices accumulating free energy from the redox gap between NADH/NAD+ and the quinone pair 
as the proton-motive force (PMF) across the coupling membranes. By observing the chemical structures of compoundⅠ、Ⅴ 
and Ⅵ, the slight difference of antibacterial activity may mainly come from the 12a-OH which connected with 12a-C (Fang 
and Beattie, 2002;Grivennikova et al., 2007). Therefore, the compounds Ⅰ,Ⅴ and Ⅵ may account for the commendable 
activity of Amorpha fruticosa L against the test pathogens, and the topical application of the three compounds on wounds 
would prevent microbes from invading the susceptible state. 
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